Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?

[1]  T. Yoshikawa,et al.  Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma , 2017, Annals of surgery.

[2]  T. Sano.  Gastric cancer: Asia and the world , 2017, Gastric Cancer.

[3]  Chang-ming Huang,et al.  Strategies of laparoscopic spleen-preserving splenic hilar lymph node dissection for advanced proximal gastric cancer. , 2016, World journal of gastrointestinal surgery.

[4]  Chang-ming Huang,et al.  A preoperatively predictive difficulty scoring system for laparoscopic spleen-preserving splenic hilar lymph node dissection for gastric cancer: experience from a large-scale single center , 2016, Surgical Endoscopy.

[5]  Chang-ming Huang,et al.  Anatomy and influence of the splenic artery in laparoscopic spleen-preserving splenic lymphadenectomy. , 2015, World journal of gastroenterology.

[6]  Chang-ming Huang,et al.  Role of 3DCT in laparoscopic total gastrectomy with spleen-preserving splenic lymph node dissection. , 2014, World journal of gastroenterology.

[7]  Chang-ming Huang,et al.  Huang's three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[8]  Chang-ming Huang,et al.  Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Proximal Gastric Cancer Using a Left Approach , 2014, Annals of Surgical Oncology.

[9]  Wang Jia-bin,et al.  Laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer in left approach: a new operation procedure , 2012, World Journal of Surgical Oncology.

[10]  A. Nashimoto,et al.  The Significance of Splenectomy for Advanced Proximal Gastric Cancer , 2012, International journal of surgical oncology.

[11]  Y. Bang,et al.  Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial , 2012, The Lancet.

[12]  Y. Ohashi,et al.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[14]  G. Tiberio,et al.  A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer Patients , 2010, Annals of surgery.

[15]  J. Yu,et al.  [Development and implementation of a clinical data mining system for gastric cancer surgery]. , 2010, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

[16]  K. Obama,et al.  Medial approach for laparoscopic total gastrectomy with splenic lymph node dissection. , 2010, Journal of the American College of Surgeons.

[17]  H. Putter,et al.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. , 2010, The Lancet. Oncology.

[18]  S. Choi,et al.  The effect of spleen‐preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer , 2009, Journal of surgical oncology.

[19]  K. Yamashita,et al.  Laparoscopy-assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy , 2009, Surgical Endoscopy.

[20]  M. Choi,et al.  Clinical Significance of Splenic Hilar Lymph Node Metastasis in Proximal Gastric Cancer , 2009, Annals of Surgical Oncology.

[21]  S. Choi,et al.  Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. , 2008, Journal of the American College of Surgeons.

[22]  S. Cai,et al.  Spleen Preservation in Radical Surgery for Gastric Cardia Cancer , 2007, Annals of Surgical Oncology.

[23]  David D. Smith,et al.  Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  D. Roukos,et al.  Impact of spleen preservation in patients with gastric cancer. , 2005, Anticancer research.

[25]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[26]  D. Corley,et al.  Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States , 2002, Cancer.

[27]  T. Sano,et al.  Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. , 2002, Japanese journal of clinical oncology.

[28]  R. Schwarz,et al.  Spleen‐preserving splenic hilar lymphadenectomy at the time of gastrectomy for cancer: Technical feasibility and early results , 2002, Journal of surgical oncology.

[29]  J. V. van Sandick,et al.  Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia , 2002, The British journal of surgery.

[30]  A. Hölscher,et al.  Splenectomy in proximal gastric cancer: Frequency of lymph node metastasis to the splenic hilus , 2001, Journal of surgical oncology.

[31]  M. Feith,et al.  Adenocarcinoma of the Esophagogastric Junction: Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1,002 Consecutive Patients , 2000, Annals of surgery.

[32]  D. Roukos.  Current Advances and Changes in Treatment Strategy May Improve Survival and Quality of Life in Patients With Potentially Curable Gastric Cancer , 1999, Annals of Surgical Oncology.

[33]  K. Evans,et al.  Surgical management of adenocarcinoma of the cardia. , 1998, American journal of surgery.

[34]  A. Stewart,et al.  Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. , 1997, Journal of the American College of Surgeons.

[35]  T. Fujita,et al.  Impact of splenectomy on circulating immunoglobulin levels and the development of postoperative infection following total gastrectomy for gastric cancer , 1996, The British journal of surgery.

[36]  J. Hermans,et al.  Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients , 1995, The Lancet.

[37]  J. Sanabria,et al.  Proposed classification of complications of surgery with examples of utility in cholecystectomy. , 1992, Surgery.

[38]  M. Brady,et al.  Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. , 1991, Archives of surgery.

[39]  A. Keats.  The ASA classification of physical status--a recapitulation. , 1978, Anesthesiology.